Peer Reviewed
Drug update
Meningococcal vaccines
Recent articles on:
Childhood immunisation
Childhood immunisation
Abstract
Although meningococcal disease is very rare, it is a sinister illness. Even with appropriate antibiotic therapy, the fatality rate is about 8 to 10%. Prevention with a safe effective vaccine is the best approach.
Key Points
There are two main types of meningococcal vaccines, a polysaccharide type, which provides short-term protection against several strains of Neisseria meningitidis, and a conjugate vaccine, which provides long-term protection against serogroup C. The conjugate vaccine is effective in infants aged under 2 years; infants in this age group do not respond to traditional polysaccharide vaccines.
Purchase the PDF version of this article
Already a subscriber? Login here.